Summary
Studies were conducted on the effect of heparin or 6-aminohexanoic acid (6-AH) on the activation of glutamic plasminogen (Glu-Plg) by streptokinase in the presence of different concentrations of buffer, NaCl and divalent cations. Heparin and 6-AH inhibited streptokinase-mediated activation of Glu-Plg using 10 mM Tris-HCl buffer pH 7.4. This inhibition was partially reversed by the addition of 0.2–1.0 mM of Mg ions. Increasing the ionic strength of Tris-HCl buffer from 10 to 50 mM or addition of 50–150 mM of NaCl to 50 mM Tris-HCl pH 7.4 inhibited the activation of Glu-Plg by streptokinase while decreasing the % inhibition by heparin over the control samples. Double reciprocal plot of the activation of Glu-Plg by streptokinase using 50 mM Tris-HCl pH 7.4 containing 100 mM NaCl showed that the addition of heparin lowered Vmax by 50% without affecting Km. To determine whether the inhibitory effect of heparin was specifically directed towards Glu-Plg or streptokinase, the ratios of the initial rate of plasmin generation in the presence of heparin over the controls were plotted against the inverse of the volume fraction of Glu-Plg or streptokinase after serial dilutions. The results indicated that the dilutions of streptokinase but not of Glu-Plg influenced the ratios, suggesting an interaction of heparin with streptokinase. Addition of 6-AH reversed the inhibitory effect of NaCl on the activation of Glu-Plg by streptokinase and the results of the near UV CD spectra of Glu-Plg showed that addition of 6-AH enhanced the spectra in this region with an increase in the ellipticity which was not affected by addition of NaCl.
Similar content being viewed by others
References
Caplan L.R., Mohr J.P., Kistler J.P., Koroshetz D.J. (1997): Should thrombolytic therapy be the first line of treatment for acute ischemic stroke? N. England Journal of Medicine, 337, 1309–1310.
Brogden R.N., Speight T.M., Avery G.S. (1973): Streptokinase: A review of clinical pharmacology, mechanism of action and therapeutic uses. Drugs., 5, 357–445.
Kosow D.P. (1975): Kinetic mechanism of the activation of human plasminogen by streptokinase. Biochemistry, 14, 4459–4465.
Topol E.J., Barry S.G., Kereiakes D.J. (1989): A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction. Circulation, 79, 281–286.
Serrano R.L., Rodriquez P., Salvatore V.P., Gonzales-Gronow M. (1996): ATP-regulated activity of the plasmin-streptokinase complex; a novel mechanism involving phosphorylation of streptokinase. Biochemical Journal, 313, 155–161.
Doctor V.M., Hill C., Jackson G.J. (1995): Effect of fucoidan during activation of human plasminogen. Thrombosis Research, 79, 237–247.
Sjoholm I., Wiman B., Wallen P. (1973): Studies on conformational changes of plasminogen induced during activation to plasmin by 6-aminohexanoic acid. European Journal of Biochemistry, 39, 471–479.
Brockway W.J., Castellino F.J. (1971): The mechanism of inhibition of plasmin activity by ε-aminocaproic acid. Journal of Biological Chemistry, 246, 4641–4644.
Bakshy A., Chibber K., Castellino F.J. (1986): Regulation of streptokinase-mediated activation of human plasminogen by fibrinogen and chloride ions. Journal of Biological Chemistry, 261, 5289–5295.
Urano T., Bakshy A., Chibber K., Castellino F.J. (1987): The reciprocal effects of ε-aminohexanoic acid and chloride ion on the activation of human [Glu] plasminogen by human urokinase. Proc. Nat’l. Acad. Sci. 84, 4031–4034.
Taylor F. B., Botts J. (1968): Purification and characterization of streptokinase with studies of streptokinase activation of plasminogen. Biochemistry, 7, 232–238.
Brockway W.J., Castellino F.J. (1974): Characterization of native streptokinase and altered streptokinase isolated from a human plasminogen activator complex. Biochemistry, 13, 2063–2070.
Jackson K. W., Tang J. (1982): Complete amino acid sequence of streptokinase and its homology with serine proteases. Biochemistry, 21, 6620–6625.
Wang X., Lin X., Loy J.A., Tang J., Zhang X.C. (1998): Crystal structure of the catalytic domain of human plasmin complexed with streptokinase. Science, 281, 1662–1665.
Kornblatt J.A., Rajotte I., Heitz F. (2001): Reaction of canine plasminogen with 6-aminohexanoate; A thermodynamic study combining fluorescence, circular dichroism, and isothermal titration calorimetry. Biochemistry, 40, 3639–3647.
Ray M.J., Hales M., March N. (2001): Epsilon-aminocaproic acid promotes the release of α2-antiplasmin during and after cardiopulmonary bypass. Blood Coagulation and Fibrinolysis, 12, 129–135.
Harris G., Doctor V.M. (2002). The effect of 6-aminohexanoic acid and fucoidan on the activation of glutamic plasminogen by streptokinase. Blood Coagulation and Fibrinolysis, 13, 355–359.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Guinn, L., Johnson, J. & Doctor, V.M. Ionic modulation of the effects of heparin and 6-aminohexanoic acid on plasminogen activation by streptokinase: The role of ionic strength, divalent cations and chloride. Eur. J. Drug Metab. Pharmacokinet. 28, 161–166 (2003). https://doi.org/10.1007/BF03190506
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03190506